Скачать или смотреть Future Directions in Breast Cancer Therapy Discussed at GCOS 2025 | Anna Blaes

In this GCOS 2025 interview, we speak with Dr. Anne Blaes, Medical Oncologist at the University of Minnesota, who shares key updates in the rapidly evolving landscape of breast cancer treatment.

Fresh from ESMO 2025, Dr. Blaes highlights major advancements, including several late-breaking abstracts on trastuzumab deruxtecan, sparking important questions about its potential use in the frontline metastatic and even curative-intent settings. She discusses which high-risk patients might benefit from the drug in the adjuvant setting, and the implications for future clinical practice.

#GCOS2025 #BreastCancer #Oncology #ESMO2025 #TrastuzumabDeruxtecan #HER2Positive #CancerResearch #MedicalOncology #BreastCancerUpdates #CancerTreatment #AdjuvantTherapy #MetastaticBreastCancer #PrecisionOncology #Genomics #ClinicalTrials #OncoDaily

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is your trusted source for the latest oncology news, expert interviews, patient stories, and cutting-edge research. Our mission is to empower the global cancer community—patients, survivors, professionals, and advocates—with timely, credible information.

Subscribe for weekly podcasts, expert conversations, and updates on groundbreaking cancer research.

🔔 New videos every day!
💻 Visit us at https://oncodaily.com/